These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 33937287)

  • 1. Performance Evaluation of BD Phoenix NMIC-413 Antimicrobial Susceptibility Testing Panel for Imipenem, Meropenem, and Ertapenem Against Clinical Carbapenem-Resistant and Carbapenem-Susceptible
    Zhang J; Jia P; Zhu Y; Zhang G; Xu Y; Yang Q
    Front Med (Lausanne); 2021; 8():643194. PubMed ID: 33937287
    [No Abstract]   [Full Text] [Related]  

  • 2. Performance evaluation of automated BD Phoenix NMIC-500 panel for carbapenemase detection in carbapenem-resistant and carbapenem-susceptible Enterobacterales.
    Cho H; Kim JO; Choi JE; Lee H; Heo W; Cha YJ; Yoo IY; Park YJ
    J Microbiol Methods; 2020 Oct; 177():106042. PubMed ID: 32890572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of BD Phoenix and disk diffusion to broth microdilution for determining cefepime susceptibility among carbapenem-resistant Enterobacterales.
    Fouad A; Simner PJ; Nicolau DP; Asempa TE
    J Clin Microbiol; 2024 Jun; 62(6):e0152023. PubMed ID: 38712928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance Evaluation of the Newly Developed BD Phoenix NMIC-500 Panel Using Clinical Isolates of Gram-Negative Bacilli.
    Park BY; Mourad D; Hong JS; Yoon EJ; Kim D; Lee H; Jeong SH
    Ann Lab Med; 2019 Sep; 39(5):470-477. PubMed ID: 31037866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance Evaluation of the Gradient Diffusion Strip Method and Disk Diffusion Method for Ceftazidime-Avibactam Against
    Zhang J; Li G; Zhang G; Kang W; Duan S; Wang T; Li J; Huangfu Z; Yang Q; Xu Y; Jia W; Sun H
    Front Microbiol; 2021; 12():710526. PubMed ID: 34603236
    [No Abstract]   [Full Text] [Related]  

  • 6. Carbapenem non-susceptibility overcalling by BD phoenix NMIC-500 panel.
    Yoo IY; Ha SI; Kim SW; Kim JK; Seok HS; Park YJ
    J Infect Chemother; 2024 Apr; ():. PubMed ID: 38570137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of carbapenem MIC for NDM-producing Enterobacterales by different AST methods.
    Lee ALH; Leung ECM; Chow VCY
    JAC Antimicrob Resist; 2024 Apr; 6(2):dlae028. PubMed ID: 38686026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbapenem susceptibility testing errors using three automated systems, disk diffusion, Etest, and broth microdilution and carbapenem resistance genes in isolates of Acinetobacter baumannii-calcoaceticus complex.
    Markelz AE; Mende K; Murray CK; Yu X; Zera WC; Hospenthal DR; Beckius ML; Calvano T; Akers KS
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4707-11. PubMed ID: 21807971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Performance of BD Phoenix CPO Detect Panels for Detection and Classification of Carbapenemase-Producing Gram-Negative Bacteria.
    Murata M; Kosai K; Akamatsu N; Matsuyama Y; Oda M; Wakamatsu A; Izumikawa K; Mukae H; Yanagihara K
    Microbiol Spectr; 2023 Jun; 11(3):e0089723. PubMed ID: 37162344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Ceftazidime-Avibactam 30/20-μg Disk, Etest versus Broth Microdilution Results When Tested against
    Han R; Yang X; Yang Y; Guo Y; Yin D; Ding L; Wu S; Zhu D; Hu F
    Microbiol Spectr; 2022 Feb; 10(1):e0109221. PubMed ID: 35019685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the BD Phoenix automated system for determining antimicrobial susceptibility against carbapenem-resistant Enterobacteriaceae compared with broth microdilution.
    Haffler ZJ; Kulengowski B; Ribes JA; Burgess DS
    Int J Antimicrob Agents; 2019 Aug; 54(2):249-254. PubMed ID: 31071467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meropenem-Vaborbactam Activity against Carbapenem-Resistant
    Castanheira M; Doyle TB; Kantro V; Mendes RE; Shortridge D
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of In Vitro Activity of Cefiderocol Against Carbapenem-Resistant Gram-Negative Bacilli by Broth Microdilution and Disk Diffusion Method: A Single-Center Study in Odisha, India.
    Nayak G; Behera B; Mohanty S; Kar P; Jena J
    Infect Drug Resist; 2022; 15():5887-5897. PubMed ID: 36237292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of disk diffusion, MIC test strip and broth microdilution methods for cefiderocol susceptibility testing on carbapenem-resistant enterobacterales.
    Bonnin RA; Emeraud C; Jousset AB; Naas T; Dortet L
    Clin Microbiol Infect; 2022 Aug; 28(8):1156.e1-1156.e5. PubMed ID: 35533970
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Sharma B; Sreenivasan P; Angrup A; Kaur S; Rana S; Kundu J; Biswal M; Ray P
    Curr Drug Saf; 2023; 18(4):563-570. PubMed ID: 36503394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of the modified Hodge test and the Carba NP test for detection of carbapenemases in Enterobacteriaceae isolates].
    Bayramoğlu G; Uluçam G; Gençoğlu Özgür Ç; Kılıç AO; Aydın F
    Mikrobiyol Bul; 2016 Jan; 50(1):1-10. PubMed ID: 27058324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Shall we report the carbapenem resistance in Pseudomonas aeruginosa and Acinetobacter baumannii strains detected by BD Phoenix system?].
    Oğünç D; Ongüt G; Ozen NS; Baysan BO; Günseren F; Dağlar D; Demirbakan H; Gültekin M
    Mikrobiyol Bul; 2010 Apr; 44(2):197-202. PubMed ID: 20549953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of meropenem/vaborbactam and comparators against non-carbapenemase-producing carbapenem-resistant Enterobacterales isolates from Europe.
    Shortridge D; Deshpande LM; Streit JM; Castanheira M
    JAC Antimicrob Resist; 2022 Oct; 4(5):dlac097. PubMed ID: 36196439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the BD Phoenix M50 Automated Microbiology System for Antimicrobial Susceptibility Testing with Clinical Isolates in Korea.
    Hong JS; Kim D; Kang DY; Park BY; Yang S; Yoon EJ; Lee H; Jeong SH
    Microb Drug Resist; 2019 Oct; 25(8):1142-1148. PubMed ID: 31161952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter Clinical Evaluation of Vitek 2 Meropenem-Vaborbactam for Susceptibility Testing of
    Dwivedi HP; Franklin S; Chandrasekaran S; Garner O; Traczewski MM; Beasley D; Procop GW; Tuohy M; Wilson D; Bala Y; Pincus DH
    J Clin Microbiol; 2022 Jan; 60(1):e0161021. PubMed ID: 34705536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.